CX-659S
CX-659S is an orally active and novel derivative of 5-carboxamide uracil. CX-659S can effectively inhibit lipid peroxidation (IC50 = 5.9 μM) . CX-659S can reduce the infiltration of neutrophils and eosinophils. CX-659S inhibits the mRNA expression of pro-inflammatory cytokines IL-1β and TNF-α. CX-659S can be used for research on inflammatory conditions[1].
Product Specifications
CAS Number
204980-81-4
UNSPSC
12352005
Target
Interleukin Related; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
CC1=C2C(CC[C@](C)(O2)C(NC3=C(N(C4=CC=CC=C4)C(N(C3=O)C)=O)N)=O)=C(C(O)=C1C)C
Molecular Formula
C25H28N4O5
Molecular Weight
464.51
References & Citations
[1]Tobe M, et al. Synthesis and biological evaluation of CX-659S and its related compounds for their inhibitory effects on the delayed-type hypersensitivity reaction. Bioorg Med Chem. 2000 Aug;8 (8) :2037-47. |[2]Goto Y, et al. Suppressive effect of topically applied CX-659S, a novel diaminouracil derivative, on the contact hypersensitivity reaction in various animal models. Int Arch Allergy Immunol. 2000 Dec;123 (4) :341-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IL-1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6495811-01 0.2 mL
PTPIA2 beta, NT (Receptor-type Tyrosine-protein Phosphatase N2, R-PTP-N2, Islet Cell Autoantigen-related Protein, IAR, ICAAR, Phogrin, PTPRN2, KIAA0387) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6495811-02 5x 0.2 mL
PTPIA2 beta, NT (Receptor-type Tyrosine-protein Phosphatase N2, R-PTP-N2, Islet Cell Autoantigen-related Protein, IAR, ICAAR, Phogrin, PTPRN2, KIAA0387) (Azide free) (HRP)
Sign In for Pricing
View Details